Zydelig safety alert

March 17, 2016

THE Therapeutic Goods Administration is investigating a “significant safety concern” involving idelalisib 100mg and 150mg tablets which are marketed in Australia as Zydelig. Product sponsor Gilead Sciences has advised the TGA of a potential increased risk of serious adverse events including death, mostly due to infections, in patients receiving the medicine for the treatment of chronic lymphocytic leukaemia and relapsed indolent non-Hodgkin’s lymphoma, in phase 3 clinical trials. The TGA is reviewing information already received and is seeking further information from Gilead. In the meantime the company is advising prescribers to avoid using idelalisib as a first line treatment.

The above article was sent to subscribers in Pharmacy Daily's issue from 17 Mar 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Mar 16

Other recent headlines

MDR’s results surpass expectations
Tuesday | Apr 23 2024

MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.

Call to restructure CSO
Tuesday | Apr 23 2024

PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).

Camden takes top spot
Tuesday | Apr 23 2024

CAMDEN Day and Night Pharmacy has clinched the top prize in the Pharmacy category at the 2024 Australian Small Business Champion Awards recently.

SEARCH PHARMACY DAILY

Featured video
MORE VIDEOS

Recent issues

PD for Tue 23 Apr 2024
PD for Mon 22 Apr 2024
PD for Fri 19 Apr 2024
PD for Thu 18 Apr 2024
PD for Wed 17 Apr 2024
SEE MORE ISSUES

INDUSTRY JOB VACANCIES

Pharmacist in Charge – SA
Pharmacist Manager – WA
Compounding Pharmacist – Melbourne
Pharmacist in Charge – QLD North
Pharmacist – Sydney North
SEE MORE JOBS

Pharmacy Daily is Australia's favourite online publication dedicated to the pharmacy industry. The publication launched in March 2007 and is distributed every day by email to pharmacists across the country.

PHARMACY DAILY NEWS
Headlines

Jobs

New Products

Events Calendar

FEEDS
News Items RSS feed

PD Issues RSS feed

All content RSS feed

Content & Media
Pharmacy Daily TV

OUR SITES
Sitemap

Travel Daily

Travel Bulletin

Cruise Weekly

Business Events News

Pharmacy Daily

ADVERTISE WITH US
Advertise in Pharmacy Daily

Privacy

ADMIN
Log in

SUBSCRIBE
Sign up for FREE

Subscription Information

"Water, air, and cleanness are the chief articles in my pharmacy." - Napoleon Bonaparte

Copyright © 2018 Pharmacy Daily

Subscribe to Pharmacy Daily now!

FREE Pharmacy Daily subscription - never miss another story!

Name*
First Last
Email*

Profession
Company

Address
City State / Province / Region ZIP / Postal Code Country

By submitting this form I hereby certify that I understand that Pharmacy Daily is a publication for health professionals.
Comments
This field is for validation purposes and should be left unchanged.

to top

Pharmacy Daily | Zydelig safety alert

Zydelig safety alert

Other recent headlines

MDR’s results surpass expectations

Call to restructure CSO

Camden takes top spot

SEARCH PHARMACY DAILY

Featured video

Recent issues

INDUSTRY JOB VACANCIES